Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
Using the pre-bronchodilator spirometry curvature to improve estimation of post-bronchodilator airflow obstruction Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019
Reference values for FEV1, FVC and FEV1/FVC in Norway Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
Comparative study of FEV1 /FVC and FEV1 /FEV6 to screen COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 511s Year: 2005
Within session variability of FEV1 and FVC pre- and post-bronchodilation Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019
Spirometric diagnosis of COPD: is postbronchodilator test reliable? Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006
FEV1/FEV6 versus FEV1/FVC in the spirometric detection of airway obstruction among Asians Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
Usefulness of FEV1/SVC to uncover airflow obstruction in subjects with preserved FEV1/FVC Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016
Distinguishing hyperinflation from combined restriction in patients with reduced FEV1 /FVC and FVC on spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 202s Year: 2006
Pre- and post-bronchodilator spirometric values and the degree of reversibility in patients with COPD Source: Eur Respir J 2004; 24: 332 Year: 2004
Changes in spirometry (FVC and FEV1 ) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects Source: Annual Congress 2013 –New issues in lung function testing Year: 2013
Forcede expiratory volume in six second in the spirometric diagnosis of COPD Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015
Natural decline in FEV1 and FVC: Self versus reference equations Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function Year: 2013
FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace Source: Eur Respir J 2006; 27: 374-377 Year: 2006
Peak-flow or portable spirometry as a replacement for Spirometry in the diagnosis of COPD and Asthma Source: International Congress 2018 – Primary care management of COPD Year: 2018
Reversibility of FEV1 , forced oscillometry and interrupter technique in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 496s Year: 2003
Reproducibility of FEV6 and FVC measurement: dependence on degree of obstruction Source: Annual Congress 2006 - Landmark developments in lung function testing: 2006 Year: 2006